| Literature DB >> 34769407 |
Dario Paolo1, Franca Locatelli1, Eleonora Cominelli1, Raul Pirona1, Sara Pozzo1, Giulia Graziani2, Alberto Ritieni2, Monica De Palma3, Teresa Docimo3, Marina Tucci3, Francesca Sparvoli1.
Abstract
Cultivated cardoon (Cynara cardunculus var. altilis L.) is a promising candidate species for the development of plant cell cultures suitable for large-scale biomass production and recovery of nutraceuticals. We set up a protocol for Agrobacterium tumefaciens-mediated transformation, which can be used for the improvement of cardoon cell cultures in a frame of biorefinery. As high lignin content determines lower saccharification yields for the biomass, we opted for a biotechnological approach, with the purpose of reducing lignin content; we generated transgenic lines overexpressing the Arabidopsis thaliana MYB4 transcription factor, a known repressor of lignin/flavonoid biosynthesis. Here, we report a comprehensive characterization, including metabolic and transcriptomic analyses of AtMYB4 overexpression cardoon lines, in comparison to wild type, underlining favorable traits for their use in biorefinery. Among these, the improved accessibility of the lignocellulosic biomass to degrading enzymes due to depletion of lignin content, the unexpected increased growth rates, and the valuable nutraceutical profiles, in particular for hydroxycinnamic/caffeoylquinic and fatty acids profiles.Entities:
Keywords: MYB4; cellulose accessibility; lignin; nutraceuticals; plant cell cultures
Mesh:
Substances:
Year: 2021 PMID: 34769407 PMCID: PMC8584892 DOI: 10.3390/ijms222111978
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Phenotype and growth of cardoon lines: (a) Calluses of wild type (WT) and AtMYBoe lines (L1, L18, L24) grown for 21 days on solid medium; (b) Relative expression level (mean ± standard deviation, S.D.) of the transgene in the three lines selected for this study. Asterisks indicate significant differences (p < 0.01); (c) Growth curves for calluses grown on solid medium (left) and for cell suspension grown in liquid medium (right). CVS: cell volume after sedimentation. Each value represents the mean of three biological replicates ± S.D.
Figure 2Phenols/lignin content and saccharification yields of 21 days-old calluses: (a) Folin–Ciocalteu’s quantification of total phenols, expressed as mg of GAE (Gallic Acid Equivalents)/g dry weight (DW) ± S.D; (b) quantification of lignin via thioglycolic acid (TGA) derivatization. Bars indicate means ± S.D. of three biological replicates. Different letters above bars indicate statistically significant differences (p < 0.01); (c) saccharification yields expressed as mean values of µg released glucose/mg DW ± S.D.
Biochemical characterization of WT and AtMYB4oe lines. Polyphenols content detected by HRMS-Orbitrap: values are expressed in ppm = µg/g dry weight, DW. 5-iFQA = 5-isoferuloyl quinic acid; 1,5-DiCQA = 1,5-dicaffeoyl quinic acid (cynarin); 3,4-DiCQA = 3,4-dicaffeoyl quinic acid; 5-FQA = 5-feruloyl quinic acid; 3-FQA = 3-feruloyl quinic acid; 3-CQA = 3-caffeoyl quinic acid (chlorogenic acid, CGA). Antioxidant activities were measured via 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-bis 3-ethylbenzothiazoline-6-sulfonic acid (ABTS) and Ferric Reducing Antioxidant Power (FRAP) assays. Values are expressed as TEAC: Trolox®-equivalent antioxidant capacity mmol Trolox/kg DW. Each value shown represents the mean values ± S.D. of three biological and two technical replicates. Fatty acids content was detected by GC-FID. Values are expressed as % of total; SFA = saturated fatty acids; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids. Different letters denote a significant difference among lines through analysis of variance (ANOVA). Statistical significance was defined as p < 0.05, using the Tukey’s post hoc test for mean separation.
| WT | L1 | L18 | L24 | ||
|---|---|---|---|---|---|
|
| 5-iFQA | 21.50 ± 1.33a | 15.41 ± 0.43b | 0.11 ± 0.04c | 4.26 ± 0.12d |
| 1,5-DiCQA (cynarin) | 3345.79 ± 112.23a | 532.70 ± 11.55b | 2.50 ± 0.81c | 352.98 ± 21.71d | |
| 3,4-DiCQA | 3152.41 ± 26.67a | 443.88 ± 12.43b | 103.58 ± 8.23c | 1615.65 ± 34.56d | |
| 5-FQA | 98.87 ± 11.34a | 5.56 ± 0.43b | 0.83 ± 0.011c | 76.44 ± 11.34d | |
| 3-FQA | 3.09 ± 0.55a | 2.71 ± 0.91b | 0.10 ± 0.01c | 10.20 ± 0.23d | |
| 3-CQA (CGA) | 319.38 ± 22.45a | 424.66 ± 11.32b | 97.28 ± 3.56c | 513.48 ± 13.57d | |
| 3.50 ± 0.02a | 3.75 ± 0.91a | 1.50 ± 0.01b | 3.85 ± 0.02a | ||
| Quercetin | 3.35 ± 0.02a | 4.30 ± 0.02b | 0.55 ± 0.01c | 4.35 ± 0.02b | |
| Quercetin-glucoside | 4.00 ± 0.65a | 5.25 ± 1.23b | 1.25 ± 0.03c | 5.40 ± 0.34b | |
| Kaempferol | 3.55 ± 0.65a | 4.30 ± 0.91b | 1.05 ± 0.03c | 4.55 ± 0.83d | |
| Kaempferol-3-O-glucoside | 1.15 ± 0.02a | 1.50 ± 0.03b | 0.40 ± 0.04c | 1.60 ± 0.04b | |
| Naringin | 1.20 ± 0.01a | 1.75 ± 0.01b | 0.41 ± 0.03c | 1.800.03b | |
| Luteolin | 1.50 ± 0.03a | 2.35 ± 0.02b | 0.60 ± 0.04c | 2.55 ± 0.04d | |
| Myricetin | 2.55 ± 0.34a | 2.96 ± 0.32b | 0.73 ± 0.11c | 3.04 ± 0.12b | |
| Apigenin | 0.20 ± 0.03a | 0.25 ± 0.02b | 0.01 ± 0.003c | 0.30 ± 0.01d | |
| Total polyphenols | 6962.05a | 1451.33b | 210.92c | 2600.46d | |
|
| DPPH | 83.7 ± 0.61a | 22.17 ± 0.42b | 16.96 ± 0.63c | 35.43 ± 5.82d |
| ABTS | 71.33 ± 0.20a | 19.16 ± 0.07b | 12.54 ± 0.26c | 23.61 ± 0.22d | |
| FRAP | 66.81 ± 0.98a | 30.84 ± 0.21b | 11.09 ± 0.08c | 27.90 ± 0.54d | |
|
| 11.38 | 8.24 | 10.35 | 7.25 | |
|
| Palmitic (C16:0) | 22.29 ± 1.12ab | 21.71 ± 0.58a | 24.06 ± 0.35b | 19.46 ± 0.38c |
| Stearic (C18:0) | 2.85 ± 0.31ab | 3.14 ± 0.54ab | 2.29 ± 0.07a | 3.73 ± 0.26b | |
| Oleic (C18:1) | 3.43 ± 1.91a | 10.30 ± 0.56b | 3.49 ± 0.27a | 12.35 ± 0.16c | |
| Linoleic (C18:2) | 19.38 ± 3.74a | 45.82 ± 0.85b | 41.04 ± 0.61c | 41.34 ± 0.39c | |
| Linolenic (C18:3) | 42.60 ± 6.34a | 10.16 ± 0.38b | 20.73 ± 0.74c | 14.46 ± 0.06d | |
| Arachidic (C20:0) | 0.80 ± 0.08a | 0.88 ± 0.01a | 0.84 ± 0.05a | 1.04 ± 0.05b | |
| Lignoceric (C24:0) | 2.42 ± 0.30a | 3.26 ± 1.59a | 2.41 ± 0.58a | 2.40 ± 0.68a | |
| Nervonic (C24:1) | 1.23 ± 0.14a | 0.18 ± 0.03b | 0.52 ± 0.47ab | 0.66 ± 0.12ab | |
| Total SFA% | 30.54 ± 0.78ab | 30.29 ± 0.76a | 32.07 ± 0.43b | 28.00 ± 0.10c | |
| Total MUFA % | 4.65 ± 1.777a | 10.48 ± 0.30b | 4.02 ± 0.21a | 13.01 ± 0.28c | |
| Total PUFA % | 61.98 ± 2.88a | 55.98 ± 0.80b | 61.77 ± 0.41a | 55.81 ± 0.42b | |
| Others % | 2.83 | 3.25 | 2.14 | 3.18 |
Figure 3Differentially expressed genes (DEGs) between AtMYB4oe lines and WT: Venn diagrams of the number of (a) downregulated and (b) upregulated genes for all comparisons (FDR < 0.05).
Figure 4Gene Ontology Expression Analysis: Gene Ontology (a) downregulated and (b) upregulated terms referred to biological processes enriched among core-DEGs.
Genes coding for transcription factors identified among the core-DEGs.
| Number of Core-DEGs | ||
|---|---|---|
| TF Family | Downregulated | Upregulated |
| AP2 | 1 | 3 |
| bHLH | 7 | 11 |
| bZIP | 5 | 4 |
| C2H2 | 1 | 6 |
| C3H | 2 | - |
| Dof | 3 | 1 |
| ERF | 2 | 6 |
| FAR1 | 1 | 2 |
| G2-like | 1 | 3 |
| GRAS | 3 | 7 |
| HB-other | 2 | - |
| HSF | 1 | 1 |
| LBD | 3 | 4 |
| MIKC_MADS | 4 | 2 |
| M-type MADS | 2 | 2 |
| MYB | 1 | 4 |
| MYB_related | 6 | 5 |
| NAC | 14 | 3 |
| NF-YA | 1 | - |
| Nin-like | 1 | - |
| S1Fa-like | 1 | - |
| TALE | 2 | 3 |
| TCP | 1 | - |
| Trihelix | 1 | 1 |
| WOX | 2 | - |
| WRKY | 9 | 6 |
| ZF-HD | 1 | 1 |
Figure 5Biosynthetic pathway of phenylpropanoids and average expression levels of the relative genes in AtMYB4oe lines vs. WT.
Figure 6Biosynthesis of oleic acid and average expression levels of the relative genes in AtMYB4oe lines vs. WT.